Bignante Gabriele, Orsini Angelo, Lasorsa Francesco, Lambertini Luca, Pacini Matteo, Amparore Daniele, Pandolfo Savio Domenico, Del Giudice Francesco, Zaytoun Osama, Buscarini Maurizio, Lucarelli Giuseppe, Schips Luigi, Veccia Alessandro, Antonelli Alessandro, Fiori Cristian, Porpiglia Francesco, Autorino Riccardo
Department of Urology, Rush University Medical Center, Chicago, IL, USA.
Division of Urology, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Expert Rev Med Devices. 2024 Dec;21(12):1165-1177. doi: 10.1080/17434440.2024.2435546. Epub 2024 Dec 1.
Recent advancements in single-port surgery, robotic platforms, 3D models and artificial intelligence have transformed surgical procedures, especially in urology. These innovations enhance precision, safety, and efficacy, reducing invasiveness and recovery times. The review focuses on the latest in robotic-assisted surgery for genitourinary cancers, highlighting the shift toward personalized, minimally invasive treatments.
A bibliographic search across PubMed, Scopus, and EMBASE databases focused on the last four years of innovations in robotic surgery for urologic tumors. The review highlights the use of the Da Vinci Single Port robotic system, available robotic platforms worldwide, advancements in 3D virtual models, artificial intelligence in robotic surgery and the application of molecular imaging for assessing primary lymph nodes and treating lymph node metastases and local recurrences in prostate cancer.
The integration of single-port surgery, new robotic platforms, 3D models and artificial intelligence in urological oncology promises transformative impacts on diagnosis, treatment and cost-effectiveness. Despite benefits like enhanced precision and expanded surgical access, challenges such as high costs, training needs, and technological integration barriers persist. Collaboration and further research are critical to optimize outcomes, improve safety protocols, and ensure equitable global access to these innovations.
单孔手术、机器人平台、3D模型和人工智能方面的最新进展已经改变了外科手术程序，尤其是在泌尿外科领域。这些创新提高了手术的精准性、安全性和有效性，减少了侵入性并缩短了恢复时间。本综述聚焦于泌尿生殖系统癌症机器人辅助手术的最新进展，突出了向个性化、微创治疗的转变。
通过对PubMed、Scopus和EMBASE数据库进行文献检索，重点关注过去四年泌尿外科肿瘤机器人手术的创新成果。本综述强调了达芬奇单孔机器人系统的使用、全球现有的机器人平台、3D虚拟模型的进展、机器人手术中的人工智能以及分子成像在评估前列腺癌原发淋巴结和治疗淋巴结转移及局部复发中的应用。
单孔手术、新型机器人平台、3D模型和人工智能在泌尿外科肿瘤学中的整合有望对诊断、治疗和成本效益产生变革性影响。尽管具有提高精准性和扩大手术入路等优势，但高成本、培训需求和技术整合障碍等挑战依然存在。合作与进一步研究对于优化治疗效果、改进安全方案以及确保全球公平获取这些创新技术至关重要。
